BioSpace News Archive

Aflac Incorporated announced today that it has priced ¥53.4 billion (par value) in yen-denominated senior notes.

AMPLEXOR’s prominence in the ‘innovation index’ reflected in customer feedback as Life Sciences firms look for more than just compliance

Themis to expand measles vector immunomodulation portfolio into oncology indications

Exclusive worldwide licence deal adding to Carrick’s rapid pipeline expansion

West Pharmaceutical Services, Inc. today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, October 25, 2018

YOFOTO (China) Health and RepliCel Life Sciences finalize investment and commence collaboration activity in Greater China

Anthem subsidiaries offer pharmacy assistance for health plan consumers and free telehealth medical and psychological help for all residents of impacted counties

DaVita Inc. announced today that it will hold its quarterly conference call to discuss third quarter results on Wednesday, November 7, 2018, at 5:00 p.m. Eastern Time.

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announce the signing of an expanded global collaboration agreement that will strengthen the relationship between the two companies for the further development and commercialization of a portfolio of medicines including the ABILIFY MYCITE® (aripiprazole tablets with sensor) offering, which received NDA approval from the U.S. Food and Drug Administration in November 2017.

Tc 99m tilmanocept is the first product developed and commercialized by the Company based on the Manocept platform.